secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2023-02-22T23:59:59+00:00
Accession:  0001157523-23-000326
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Q4 revenue $1.10B (+21.5% YoY); DOJ subpoena on NHP supply; 2023 guidance below expectations
--------------------------------------------------------------------------------

- Q4 GAAP EPS $3.65, non-GAAP EPS $2.98; full-year GAAP EPS $9.48, non-GAAP EPS $11.12.
- Q4 organic revenue growth 18.8% led by DSA segment (+26.5% organic).
- Received DOJ subpoena on Cambodian NHP supply chain; voluntarily suspended shipments from Cambodia.
- 2023 guidance: reported revenue growth 1.5%-4.5%, organic 4.5%-7.5%; GAAP EPS $7.40-$8.60, non-GAAP $9.70-$10.90.
- NHP supply constraints expected to reduce 2023 revenue growth by 200-400 bps; higher tax and interest to pressure EPS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000115752323000326/0001157523-23-000326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000115752323000326/a53335402.htm
  HTML page:      https://secwatch.observer/filing/0001157523-23-000326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer